206 related articles for article (PubMed ID: 6616448)
1. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
Piper AA; Nott SE; Mackinnon WB; Tattersall MH
Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
[TBL] [Abstract][Full Text] [Related]
2. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Samuels LL; Straw JA
Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
[TBL] [Abstract][Full Text] [Related]
3. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
Sobrero AF; Bertino JR
Int J Cell Cloning; 1986 Jan; 4(1):51-62. PubMed ID: 2936838
[TBL] [Abstract][Full Text] [Related]
4. Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
Fried J; Perez AG; Doblin JM; Clarkson BD
Cell Tissue Kinet; 1983 Nov; 16(6):539-48. PubMed ID: 6627345
[TBL] [Abstract][Full Text] [Related]
5. Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells.
Muggia FM; Slowiaczek P; Tattersall MH
Anticancer Res; 1987; 7(2):161-6. PubMed ID: 3592628
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate cytotoxicity: studies on its reversal by folates and nucleosides.
Leyva A; Nederbragt H; Lankelma J; Pinedo HM
Cancer Treat Rep; 1981; 65 Suppl 1():45-50. PubMed ID: 6173122
[TBL] [Abstract][Full Text] [Related]
7. Purine modulation of methotrexate cytotoxicity in mammalian cell lines.
Taylor IW; Slowiaczek P; Francis PR; Tattersall MH
Cancer Res; 1982 Dec; 42(12):5159-64. PubMed ID: 6958362
[TBL] [Abstract][Full Text] [Related]
8. Effects of extracellular purines on cytotoxicity of methotrexate.
Chong L; Ma G; Bartier WA; Tattersall MH
Cancer Chemother Pharmacol; 2010 May; 66(1):121-7. PubMed ID: 19784836
[TBL] [Abstract][Full Text] [Related]
9. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
Santelli G; Valeriote F
J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
Taylor IW; Tattersall MH
Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
[TBL] [Abstract][Full Text] [Related]
11. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
Zhen YS; Taniki T; Weber G
Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
Mini E; Moroson BA; Bertino JR
Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
[TBL] [Abstract][Full Text] [Related]
13. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
[TBL] [Abstract][Full Text] [Related]
14. Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.
Danhauser LL; Heimer R; Cadman E
Cancer Chemother Pharmacol; 1985; 15(3):214-9. PubMed ID: 3876889
[TBL] [Abstract][Full Text] [Related]
15. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
Fernandes DJ; Moroson BA; Bertino JR
Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
[TBL] [Abstract][Full Text] [Related]
16. Role of methotrexate polyglutamates in methotrexate- and sequential methotrexate-5-fluorouracil-mediated cell kill.
McGuire JJ; Mini E; Hsieh P; Bertino JR
Cancer Res; 1985 Dec; 45(12 Pt 1):6395-400. PubMed ID: 2415244
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Cole PD; Smith AK; Kamen BA
Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of methotrexate toxicity by dipyridamole.
Nelson JA; Drake S
Cancer Res; 1984 Jun; 44(6):2493-6. PubMed ID: 6586287
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.
Smith SG; Lehman NL; Moran RG
Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626
[TBL] [Abstract][Full Text] [Related]
20. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
